Ahmet Hacıislamoğlu

Ahmet Hacıislamoğlu

Auto-generated profile, based on publicly available information

Ahmet Hacıislamoğlu

UNIVERSITY OF HEALTH SCIENCES, İSTANBUL BAKIRKÖY DR. SADİ KONUK TRAINING RESEARCH CENTER

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
SKSerdar Karadag
Serdar Karadag
MEMithat Eksi
Mithat Eksi
OOOsman Ozdemir
Osman Ozdemir
TKTaner Kargi
Taner Kargi
AHAhmet Haciislamoglu
Ahmet Haciislamoglu
VTVolkan Tugcu
Volkan Tugcu
Background. The gold standard treatment method for end‐stage renal disease (ESRD) is renal transplantation (RT). RT can be done with open or minimally invasive surgical methods. We aimed to compare the outcomes between patients who underwent robot‐assisted renal transplantation (RART) and open renal transplantation (ORT). Methods. Data of the patients who underwent ORT or RART in two institutions between June 2015 and February 2020 were retrospectively reviewed. Patients who underwent live donor RT were included, and all donor nephrectomy procedures were performed by the laparoscopic technique. Demographic data, ischemia times, anastomosis times, operation times, and postoperative complications were recorded. Results. 98 patients were included in the ORT group, while 91 patients were included in the RART group. There was a significant difference between the two groups regarding mean patient age. While total ischemia time was 86.9 ± 7 minutes in the RART group, it was calculated as 71.2 ± 3.3 minutes in the ORT group, with a significant difference. The anastomosis time was significantly shorter in the ORT group than in the RART group. The incision length and duration of hospital stay were significantly shorter, visual analogue scores were significantly lower, and estimated blood loss was less in the RART group than in the ORT group. Conclusion. Both ORT and RART are effective and safe methods for treating ESRD. According to our study, RART is associated with relatively longer ischemia times but lower complication rates and higher patient comfort.

1 January 2021 in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
Verified
Journal Article
Open access
MEMithat Eksi
Mithat Eksi
DODeniz Noyan Ozlu
Deniz Noyan Ozlu
TKTaner Kargi
Taner Kargi
AYAbdullah Hizir Yavuzsan
Abdullah Hizir Yavuzsan
AHAhmet Haciislamoglu
Ahmet Haciislamoglu
ATAli Ihsan Tasci
Ali Ihsan Tasci
The Medical Bulletin of Sisli Etfal Hospital


24 April 2020 in Cureus
Verified
Journal Article
Open access
PDF file
DODeniz Noyan Ozlu
Deniz Noyan Ozlu
KSKamil Gokhan Seker
Kamil Gokhan Seker
YSYurdagul Cetin Seker
Yurdagul Cetin Seker
AHAhmet Haciislamoglu
Ahmet Haciislamoglu
NKNadir Kalfazade
Nadir Kalfazade
An 88-year-old woman presented to the emergency department with abdominal distention, fever, and constipation of about a week's duration. Laboratory tests showed impaired kidney function tests and fluid electrolyte values. Bilateral hydroureteronephrosis was observed on non-contrasted abdominal CT. Imaging revealed no intrinsic urological pathology (ureteral stones, etc.) that could lead to obstruction in the urinary system; however, excessively dilated and feces-loaded rectum and colon were observed. The patient was treated with conservative methods. Unfortunately, she passed away due to general condition disorder.

27 February 2023 in Yeni Üroloji Dergisi
Verified
Journal Article
Closed access
PDF file
TKTaner Kargi
Taner Kargi
ABAlper Bitkin
Alper Bitkin
USUbeyd Sungur
Ubeyd Sungur
SKSerdar Karadağ
Serdar Karadağ
IEİsmail Evren
İsmail Evren
ATAli İhsan Taşçi
Ali İhsan Taşçi
Objective: In this study, we aimed to evaluate the effect of large prostate volume on surgical, oncological and functional outcomes in prostate cancer patients who underwent Robot-assisted radical prostatectomy (RARP). Material and Methods: In this study, patients who underwent RARP due to prostate cancer by a single surgeon were divided into two groups as large prostate volume over 75 cc (Group-1) and prostate volume less than 75 cc (Group-2), and these two groups were compared retrospectively. Patients who were followed up for 12 months were assessed. Results: There was no significant difference between the two groups in terms of age, preoperative PSA level, clinical stage distributions, Gleason score, D’Amico risk classification, preoperative potency and continence assessment (p>0.05). The operative time was 169.9 ± 62.5 minutes and 145.6 ± 56.1 minutes in Groups 1 and 2, respectively, and was significantly higher in Group 1 (p= 0.02). Bladder neck reconstruction was performed in 17 (35%) and 2 (3%) patients in Groups 1 and 2, respectively, and it was statistically significantly higher in Group-1 (p=0.001). After removal of the urethral catheter in Group 1 and Group 2, full continence and potency rates were similar during the 1-year follow-up (p >0.05). Biochemical recurrence rates at 6 months and 1 year were similar in Group 1 and Group 2 (p >0.05). Conclusion: In prostate cancer patients with large prostate volume, RARP results in longer operative time and bladder neck reconstruction may be required.. However, in operations performed by experienced surgeons, large prostate volume does not have a negative effect on surgical, functional and oncological outcomes. Keywords: robotic surgical procedures, prostatectomy, prostate, organ size

27 February 2023 in Yeni Üroloji Dergisi
Verified
Journal Article
Open access
PDF file
AHAhmet Haci̇i̇slamoğlu
Ahmet Haci̇i̇slamoğlu
AYAbdullah Hizir Yavuzsan
Abdullah Hizir Yavuzsan
Objective: To evaluate the efficacy of tadalafil 5mg+solifenacin 5mg combination in terms of lower urinary tract symptoms (LUTS) and erectile functions in benign prostate hyperplasia patients with predominant storage symptoms. Material and Methods: Male patients over the age of 40 who presented with LUTS with predominant storage symptoms between January 2019 and December 2021 were included into the study. Daily tadalafil 5mg and solifenacin 5mg treatment were started to the patients. Overactive bladder symptom score (OABSS), international prostate symptom score (IPSS) for LUTS, and international erectile function index-erectile function (IIEF-EF) questionnaires were used for erectile function. Frequency of daily urinary frequency, frequency of nocturia, urgency and urinary incontinence were analyzed with a three-day bladder diary. Twelve weeks later, IPSS, OABSS and IIEF-EF scores of the patients were evaluated. Results: When the symptom scores and bladder diaries of the patients before and after 12 weeks of treatment were compared, significant decrease in IPSS scores (both voiding, storage and total) (p<0.001 for each), significant increase in IIEF-EF scores (p<0.001), and significant increase in Qmax value elevation was observed. When the bladder diaries were compared, the number of daytime micturitions, the number of nocturia and the number of urgency decreased in the 12th month after tadalafil+solifenacin treatment (p<0.001). Conclusion: The combination of tadalafil 5mg and solifenacin 5mg daily is an effective and safe treatment for male patients with storage symptoms predominant LUTS/ED. Keywords: benign prostate hyperplasia, storage, tadalafil, solifenacin, erectile function